The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

So those following the field know that there have been g cases developed peripherally for the treatment of Gaucher disease, but there’s also central involvement, not only in Gaucher disease ...

Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies ...

Up to thirty percent of Lewy body dementia patients develop Lewy body dementia because they have mutations in these genes. And there is a third rare disease called Gaucher disease and again also ...

At least 1,318 people have exhibited symptoms and 53 have died, the WHO said. The U.S. Centers for Disease Control and Prevention is closely monitoring an unknown disease that has killed dozens in ...

Importance: Gaucher disease (GD) is a rare lysosomal storage disorder with limited treatment options for pediatric patients. Oral substrate reduction therapy (SRT) with eliglustat offers a potential ...

England’s NHS will routinely fund Sanofi/Genzyme’s Cerdelga (eliglustat) for the rare condition Gaucher disease after a recommendation from NICE. The cost effectiveness body published final ...

A mysterious viral disease has emerged in parts of western Democratic Republic of the Congo (DRC) in recent weeks, resulting in at least 53 deaths, officials say. According to the World Health ...